---
title: "Davion Healthcare tumbles 11%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303971886.md"
description: "Davion Healthcare fell 10.71% to US$1.500. Down 87.76% over ten sessions and down 87.76% from first-day open."
datetime: "2026-11-02T14:32:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303971886.md)
  - [en](https://longbridge.com/en/news/303971886.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303971886.md)
generator: "portal-rs"
---

# Davion Healthcare tumbles 11%

Davion Healthcare (DAVI.US) tumbled nearly **11%** during regular trading to **$1.50**.

The stock is down 87.76% over the past ten sessions and down 87.76% from its first-day open. It sits 87.80% below its 52-week high of US$12.30. The intraday swing reached 10.71%.

The Nasdaq Composite is down 2.15% over the past five sessions and up 10.18% year to date.

The company completed the acquisition of WoundSkan and Spektra Lateral Flow Test intellectual property from Humaskan shareholders for $25 million, paid in cash and newly issued shares. The stock had fallen more than 18% in premarket trading following the announcement.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [DAVI.US](https://longbridge.com/en/quote/DAVI.US.md)

## Related News & Research

- [Davion Healthcare Names Jack Kaye Interim CEO](https://longbridge.com/en/news/306327745.md)
- [Davion Healthcare Plc Agrees to Terms in Acquisition of Independence Care Homecare Network | DAVI Stock News](https://longbridge.com/en/news/305673184.md)
- [Davion Healthcare agrees to buy Independence Care businesses for up to US$10 million](https://longbridge.com/en/news/305672757.md)
- [Davion Healthcare Targets USD 100 Million in Acquisition Financing for 2027](https://longbridge.com/en/news/304637481.md)
- [Davion Healthcare agrees to buy Healthcare Stat Homecare for $13.5 million](https://longbridge.com/en/news/303566179.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**